Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.355
-0.075 (-5.24%)
At close: Sep 5, 2025, 4:00 PM
1.420
+0.065 (4.80%)
After-hours: Sep 5, 2025, 6:19 PM EDT
Sunshine Biopharma Market Cap
Sunshine Biopharma has a market cap or net worth of $6.17 million as of September 5, 2025. Its market cap has increased by 84.25% in one year.
Market Cap
6.17M
Enterprise Value
-3.20M
1-Year Change
84.25%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since October 30, 2009, Sunshine Biopharma's market cap has decreased from $160.32M to $6.17M, a decrease of -96.15%. That is a compound annual growth rate of -18.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 6.17M | 2.91% |
| Dec 31, 2024 | 6.00M | -13.95% |
| Dec 29, 2023 | 6.97M | -51.77% |
| Dec 30, 2022 | 14.45M | -52.26% |
| Dec 31, 2021 | 30.28M | 480.17% |
| Dec 31, 2020 | 5.22M | 1,941.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |